The predictive significance of CD20 expression in B-cell lymphomas

被引：0
|
作者：
Veronika Kloboves Prevodnik
Jaka Lavrenčak
Mateja Horvat
Barbara Jezeršek Novakovič
机构：
[1] Institute of Oncology,Department of Cytopathology
[2] Bayer d.o.o,Department of Medical Oncology
[3] Institute of Oncology,undefined
来源：
Diagnostic Pathology | / 6卷
关键词：
Chronic Lymphocytic Leukemia; CD20 Expression; Follicular Lymphoma; Mantle Cell Lymphoma; Hairy Cell Leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies
    Treon, SP
    Mitsiades, C
    Mitsiades, N
    Young, G
    Doss, D
    Schlossman, R
    Anderson, KC
    JOURNAL OF IMMUNOTHERAPY, 2001, 24 (03): : 263 - 271
  • [42] Effect of interferon-α on CD20 antigen expression of B-cell chronic lymphocytic leukemia
    Sivaraman, S
    Venugopal, P
    Ranganathan, R
    Deshpande, CG
    Huang, X
    Jajeh, A
    Gregory, SA
    O'Brien, T
    Preisler, HD
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 2000, 6 (02) : 81 - 87
  • [43] The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
    Serbanica, Andreea Nicoleta
    Popa, Delia Codruta
    Caruntu, Constantin
    Pasca, Sergiu
    Scheau, Cristian
    Serbanica, Ionut Vlad
    Suciu, Raluca
    Tica, Valeria
    Busescu, Elisa
    Cima, Luminita Nicoleta
    Jardan, Cerasela
    Dragomir, Mihaela
    Coriu, Daniel
    Colita, Andrei
    Colita, Anca
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [44] Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
    Johnson, Nathalie A.
    Boyle, Merrill
    Bashashati, Ali
    Leach, Stephen
    Brooks-Wilson, Angela
    Sehn, Laurie H.
    Chhanabhai, Mukesh
    Brinkman, Ryan R.
    Connors, Joseph M.
    Weng, Andrew P.
    Gascoyne, Randy D.
    BLOOD, 2009, 113 (16) : 3773 - 3780
  • [45] Restoration of rituximab sensitivity in CD20 negative B-Cell lymphoma, cells; Epigenetic change of CD20 expression after treatment of rituximab.
    Tomita, Akihiro
    Hiraga, Junji
    Kiyoi, Hitoshi
    Kinoshita, Tomohiro
    Naoe, Tornoki
    BLOOD, 2006, 108 (11) : 155B - 155B
  • [46] Prognostic significance of CD5 expression in diffuse large B-cell lymphomas.
    Yamaguchi, M
    Seto, M
    Morishima, Y
    Ichinohasama, R
    Okamoto, M
    Nakamura, N
    Yoshino, T
    Suzumiya, J
    Ueda, R
    Nakamura, S
    BLOOD, 2000, 96 (11) : 506A - 506A
  • [47] Prognostic significance of CD21 expression in diffuse large B-cell lymphomas.
    Yamaguchi, M
    Ogawa, S
    Oka, K
    Taniguchi, M
    Ito, M
    Nishii, K
    Kobayashi, T
    Shiku, H
    BLOOD, 2002, 100 (11) : 351A - 351A
  • [48] Frequency and Significance of TdT Expression in Large B-cell Lymphomas
    Bhavsar, Shweta
    Gibson, Sarah
    Moore, Erika
    Swerdlow, Steven
    LABORATORY INVESTIGATION, 2019, 99
  • [49] Frequency and Significance of TdT Expression in Large B-cell Lymphomas
    Bhavsar, Shweta
    Gibson, Sarah
    Moore, Erika
    Swerdlow, Steven
    MODERN PATHOLOGY, 2019, 32
  • [50] Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression
    Davis, TA
    Czerwinski, DK
    Levy, R
    CLINICAL CANCER RESEARCH, 1999, 5 (03) : 611 - 615
12345